Expertise in
1
conditions

Jakob S. Madsen

Aalborg, DK 
Expertise in
1
conditions
Aalborg, DK 

Overview

Jakob Madsen practices practicing medicine in Aalborg, Denmark.

Mr. Madsen is highly rated in 1 condition, according to our data. His clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Hodgkin Lymphoma.

He is actively involved in clinical research, co-authoring 18 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Aalborg, Denmark
Other Locations
Arhus, Denmark
Aarhus C, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Drug, Other
Study Drugs: Brentuximab vedotin, Rituximab, Lenalidomide
Study Phase: Phase 3

18 Total Publications

Clinical follow-up using patient-reported outcome (PRO) for patients with lymphoma and chronic lymphocytic leukemia in a hematological outpatient clinic: a Danish prospective study.
Clinical follow-up using patient-reported outcome (PRO) for patients with lymphoma and chronic lymphocytic leukemia in a hematological outpatient clinic: a Danish prospective study.
Journal: Scientific reports
Published: November 07, 2025

Frequently Asked Questions about Jakob S. Madsen

Is Jakob S. Madsen a top-rated expert for Diffuse Large B-Cell Lymphoma (DLBCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Jakob S. Madsen is classified as an Advanced expert for Diffuse Large B-Cell Lymphoma (DLBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jakob S. Madsen participate in research or clinical trials?

Yes. Jakob S. Madsen has published 18 articles and abstracts on conditions like Diffuse Large B-Cell Lymphoma (DLBCL). You can view a list of Jakob S. Madsen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Madsen's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile